ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,721Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 1499

$1.05M Total Retail Price of All Prescriptions

Rank: 63 out of 1499

665 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 665 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,598 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 768 538 1 3
LEVOTHYROXINE SODIUM 762 553 2 2
LISINOPRIL 628 379 3 1
OMEPRAZOLE 548 342 4 5
METOPROLOL TARTRATE 435 244 5 10
FUROSEMIDE 415 281 6 7
AMLODIPINE BESYLATE 407 265 7 6
RANITIDINE HCL 356 162 8 15
HYDROCODONE-ACETAMINOPHEN 354 230 S3 9 4
METFORMIN HCL ER 320 245 10 53
METFORMIN HCL 303 185 11 8
POTASSIUM CHLORIDE 288 147 12 11
WARFARIN SODIUM 270 208 13 12
FLUOXETINE HCL 260 103 14 43
CITALOPRAM HBR 248 183 15 14
ATORVASTATIN CALCIUM 239 140 16 17
HYDROCHLOROTHIAZIDE 235 165 17 9
CRESTOR 220 96 18 34
ZOLPIDEM TARTRATE 202 125 19 23
LOSARTAN POTASSIUM 200 141 20 26
TRAZODONE HCL 195 127 21 32
GABAPENTIN 192 111 22 13
TRAMADOL HCL 191 105 23 16
METOPROLOL SUCCINATE 188 102 24 20
FLUTICASONE PROPIONATE 185 99 25 31
NEXIUM 183 62 26 28
ALENDRONATE SODIUM 178 160 27 33
PROAIR HFA 174 43 28 30
CELEBREX 162 108 29 77
JANUVIA 159 79 30 84
ISOSORBIDE MONONITRATE ER 156 110 31 51
DIOVAN 144 128 32 58
CLOPIDOGREL 138 79 33 39
GLIMEPIRIDE 138 138 33 38
PREDNISONE 134 76 35 42
LOVASTATIN 132 78 36 19
DONEPEZIL HCL 129 111 37 35
SPIRIVA 126 64 38 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 73 39 25
ADVAIR DISKUS 125 68 39 37
ALLOPURINOL 122 76 41 36
PRAVASTATIN SODIUM 119 103 42 18
CYCLOBENZAPRINE HCL 112 35 R 43 41
SERTRALINE HCL 109 52 44 24
TRICOR 106 58 45 103
ATENOLOL 104 85 46 21
LANTUS 104 59 46 46
VENLAFAXINE HCL ER 103 43 48 96
CARVEDILOL 101 48 49 22
LOVAZA 95 71 50 136
SINGULAIR 93 39 51 67
COMBIVENT 93 49 51 78
PANTOPRAZOLE SODIUM 93 51 51 48
TAMSULOSIN HCL 93 57 51 29
GEMFIBROZIL 92 64 55 88
CYMBALTA 92 53 55 40
PAROXETINE HCL 91 84 57 59
GLIPIZIDE ER 91 45 57 129
MELOXICAM 89 62 59 27
GLYBURIDE 86 86 R 60 69
ENALAPRIL MALEATE 83 63 61 75
BENAZEPRIL HCL 80 48 62 93
PLAVIX 80 45 62 54
ACTOS 79 46 64 145
SPIRONOLACTONE 76 49 65 61
NOVOLIN R 72 54 66 206
LIPITOR 72 46 66 107
DIGOXIN 71 59 68 56
IBUPROFEN 69 22 69 70
MIRTAZAPINE 69 43 69 50
NAMENDA 68 56 71 47
INSULIN SYRINGE 67 40 72 102
KLOR-CON 10 66 62 73 112
VENTOLIN HFA 62 19 74 148
TRIAMTERENE-HCTZ 60 35 75 62
CEPHALEXIN 59 47 76 83
DOXYCYCLINE HYCLATE 59 31 76 106
MONTELUKAST SODIUM 58 26 78 133
AMOXICILLIN 57 35 79 113
AMLODIPINE BESYLATE-BENAZEPRIL 57 36 79 109
CHLORTHALIDONE 55 42 81 168
ZETIA 53 23 82 91
SYMBICORT 53 32 82 121
LYRICA 52 25 84 90
GLIPIZIDE 51 41 85 64
EVISTA 51 43 85 132
FENTANYL 51 30 S2 85 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.